PELMEG
As listed in the register: PELMEG 6 mg, solution injectable en seringue préremplie
6 mg · solution injectable
- Prescription only
- Active substance
- Pegfilgrastim
- Made by
- MUNDIPHARMA CORPORATION (IRELAND)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Neulasta). It describes the substance, not this exact product.
Pegfilgrastim is a colony-stimulating factor that acts on hematopoietic cells by binding to specific cell surface receptors, thereby stimulating proliferation, differentiation, commitment, and end cell functional activation.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-08-10
Safety of the active substance
From the US prescribing label for the same active substance (Neulasta). It describes the substance, not this exact product.
- Neulasta is contraindicated in patients with a history of a serious hypersensitivity reaction to pegfilgrastim or filgrastim.
- Reactions have included anaphylaxis [see Warnings and Precautions (5.3) ].
- In patients with a history of serious hypersensitivity reaction to pegfilgrastim or filgrastim.
The most common adverse reactions occurring in ≥ 5% of patients and with a between-group difference of ≥ 5% higher in the pegfilgrastim arm in placebo-controlled clinical trials are bone pain and pain in extremity.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
Spain6 matching products
CanadaNo exact match for this strength and form
Netherlands12 matching products
- Cegfila 6 mg 6 mg · oplossing voor injectie
- Dyrupeg 6 mg oplossing voor injectie in voorgevulde spuit 6 mg · oplossing voor injectie
- Fulphila 6 mg 6 mg · oplossing voor injectie
- Grasustek 6 mg oplossing voor injectie in voorgevulde spuit 6 mg · oplossing voor injectie
- Neulasta 6 mg 6 mg · oplossing voor injectie
- Nylaspeg 6 mg oplossing voor injectie in een voorgevulde spuit 6 mg · oplossing voor injectie
- Nyvepria 6 mg 6 mg · oplossing voor injectie
- Pelgraz 6 mg oplossing voor injectie 6 mg · oplossing voor injectie
Details
| Made by | MUNDIPHARMA CORPORATION (IRELAND) |
|---|---|
| Active substance | Pegfilgrastim |
| Strength | 6 mg |
| Form | solution injectable |
| Route | sous-cutanée |
| Dispensing (as stated by the register) | prescription initiale hospitalière trimestrielle · liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/18/1328 |
| Name in the register | PELMEG 6 mg, solution injectable en seringue préremplie |
| Packs | 1 seringue préremplie en verre de 0,6 mL avec système automatique de protection de l’aiguille. · 1 seringue préremplie en verre de 0,6 mL avec système automatique de protection de l’aiguille.(distributeur parallèle : DIFARMED). · 1 seringue préremplie en verre de 0,6 mL avec système automatique de protection de l’aiguille.(distributeur parallèle : BB Farma). · 1 seringue(s) préremplie(s) en verre de 0,6 ml avec dispositif(s) de sécurité de l'aiguille, (distributeur parallèle : Abacus Medicine A/S) · 1 seringue(s) préremplie(s) en verre de 0,6 ml avec système automatique de protection de l’aiguille (distributeur parallèle : Pharmalab) |
| CIS | 61378153 |
| CIP13 | 3400930163481 |
| CIP13 | 3400949500826 |
| CIP13 | 3400949500970 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.